🇺🇸 Rapport Therapeutics, Inc.RAPP

Company Update Form 8-K 20-10-2026 06:05:17 EDT

Subject: 8-K Items 7.01, 8.01, 9.01

Overview: Announced positive topline Phase 2 results for RAP-219 in bipolar mania, meeting primary endpoints with a 3.1-point placebo-adjusted YMRS improvement at Week 3.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest